BearingPoint’s latest research indicates that by 2030 a vast majority of people expect to be using a single platform for all mobility services
New BearingPoint study calls on companies and government organizations to act now or miss their opportunity in the mobility ecosystem of 2030 AMSTERDAM–(BUSINESS... Read more.
Abu Dhabi Securities Exchange (ADX) Leverages ICE Global Network to Offer Direct Market Access to Global Investors
ATLANTA & NEW YORK & ABU DHABI, United Arab Emirates–(BUSINESS WIRE)–Abu Dhabi Securities Exchange (ADX), one of the largest financial markets... Read more.
Emerging European Embedded Finance Leader Swan Opens Office in Amsterdam and Launches Localized Dutch Accounts
Launch of localized accounts will allow Swan’s Dutch customers to issue NL IBANs to their clients. AMSTERDAM–(BUSINESS WIRE)–Swan, the emerging European... Read more.
FlexTrade Hires New Head of Fixed Income Sales
Michael Kovach joins the firm to further drive the adoption of FlexFI, FlexTrade’s Fixed Income EMS (Execution Management System). GREAT NECK, N.Y.–(BUSINESS... Read more.
I-care Group Closes Largest Contract Ever With AB InBev in More Than 50 Countries
MONS, Belgium–(BUSINESS WIRE)–I-care Group, a global leader in machine health, is pleased to announce that a service partnership has been established... Read more.
Syngenta Group Reports 9M 2023 Results
9 M Group sales at $24.3 billion Q3 Group sales at $6.8 billion 9M EBITDA at $3.5 billion Q3 EBITDA at $0.3 billion BASEL, Switzerland & SHANGHAI–(BUSINESS... Read more.
VANFLYTA® Approved in the EU as the First FLT3 Inhibitor Specifically for Patients with Newly Diagnosed FLT3-ITD Positive AML
Approval based on QuANTUM-First results demonstrating VANFLYTA added to chemotherapy improved overall survival Second innovative medicine from the oncology pipeline... Read more.
Group Financial Results as of September 30th 2023 Approved Solid Growth Performance in Line With Plan, With Continued EBITDA Margin Expansion
Revenues at € 2,448.8 million in 9M23, +7.0% Y/Y; EBITDA at € 1,267.7 million in 9M23, +10.2% Y/Y, with a continued EBITDA margin expansion of c.+149 bps Sale... Read more.
Almirall’s Nine-month 2023 Results:
Almirall achieves Net Sales growth of 6.4%, driven by strong European dermatology performance Almirall’s European Dermatology business continued to be the... Read more.
New Snow Software Survey Finds AI Driving 2024 IT Agenda, with 82% of Leaders Completely Prepared to Leverage Generative AI
IT also juggling priorities including reducing security risks, curbing overspend, shifting towards platforms and more STOCKHOLM & AUSTIN, Texas–(BUSINESS... Read more.